The Delhi High Court overturned the Deputy Controller’s decision rejecting Axcess Limited’s patent application. The Court ruled that the amended claims were within the scope of the original application and remanded the case for fresh consideration, providing guidance on permissible amendments under the Patents Act, 1970.
Read more about Claim Amendments within the Scope of Patent Specification are Permissible, the Delhi High Court reiteratesTag: Patents Act
CASE BRIEF: FMC Corporation & Ors. vs. Natco Pharma Limited
Facts (with Timeline): i) FMC Corporation and FMC Agro Singapore Pte. Ltd. (collectively referred to as “Plaintiffs”) were assigned Indian Patent No. 298645 (suit patent/IN’645) titled...
Read more about CASE BRIEF: FMC Corporation & Ors. vs. Natco Pharma LimitedCASE BRIEF: Novo Nordisk AS vs. Union of India & Ors.
Facts (with Timeline): On 4th October, 2013, Novo Nordisk (hereinafter referred to as “Patentee”) was issued patent IN 257402. On 29th September, 2014, which is five...
Read more about CASE BRIEF: Novo Nordisk AS vs. Union of India & Ors.Delhi High Court asks the Patent Office to decide on amendments and give adequate opportunity in Opposition Proceedings
In a recent decision, the Delhi High Court gave clarity about how amended claims during opposition proceedings have to be dealt with by the Controller...
Read more about Delhi High Court asks the Patent Office to decide on amendments and give adequate opportunity in Opposition ProceedingsUpdated Patent, Trade Mark, Copyright and other Acts
Following the ordinance abolishing the IPAB, we updated all relevant intellectual property statutes to reflect the amended provisions. We are hereby sharing the links to...
Read more about Updated Patent, Trade Mark, Copyright and other ActsDelhi High Court Patent Rules: Comments
The Delhi High Court published the draft of the proposed High Court of Delhi Rules governing Patent Suits, 2020 on 9th of October 2020 and...
Read more about Delhi High Court Patent Rules: CommentsCPI(M) asks Government to issue compulsory license for Remdesivir, EPO creates search strategies to help fight against COVID-19 and more patent news
In this week’s Patent News – CPI(M) asks Government to issue compulsory license for manufacturing generic versions of drug – Remdesivir; EPO creates search strategies...
Read more about CPI(M) asks Government to issue compulsory license for Remdesivir, EPO creates search strategies to help fight against COVID-19 and more patent news